Anupam Rasayan acquires 48.2% stake in Bliss GVS Pharma for ₹1,750 crore
By United One News · AI-generated summary of 1 outlets' reporting
Published
AI-generated summary of the coverage listed below:
- Anupam Rasayan, a Surat‑based specialty chemicals maker, has completed a ₹1,750 crore purchase of a 48.2% stake in Bliss GVS Pharma.
- This transaction is the company’s third strategic inorganic deal, expanding its presence into finished pharmaceutical formulations.
Covered by 1 outlet across the spectrum: 0% left, 100% center, 0% right.
How each side framed it
Surat-based Anupam Rasayan completes ₹1,750-cr acquisition of 48.2% in Bliss GVS Pharma
Timeline
First reported by The Hindu BusinessLine on ; 1 article from 1 outlets so far.
Who is covering this story
- Center (1): The Hindu BusinessLine
Sources
- Surat-based Anupam Rasayan completes ₹1,750-cr acquisition of 48.2% in Bliss GVS Pharma — The Hindu BusinessLine (center, AI-estimated) ·